Deep Tech Startups

Analog Craft develops AI-native software and copilots for analog and mixed-signal integrated circuit design, aimed at semiconductor engineering teams. Its tools integrate into existing chip design workflows to speed up development and reduce design risk.

1 investor

AnalytiCon Discovery specializes in natural product research and development, providing natural compound libraries and collections along with discovery and development technologies. It serves the pharmaceutical, cosmetic, and nutritional product industries.

1 investor

Anatoscope develops software that reconstructs and simulates a digital twin of a patient from data such as medical imaging or surface scans, working at the intersection of medical imaging and computer-aided design (CAD). Founded as a spin-off from Inria, CNRS, and the Grenoble-Alpes and Montpellier universities, it applies biomechanical simulation and digital design across medical fields via its subsidiaries.

1 investor

AncSonic develops intelligent acoustic technologies, including acoustic holography and advanced sound processing algorithms, for earphone, home appliance, and automotive manufacturers. The company offers solutions for active noise cancellation, beamforming, and spatial audio applications.

1 investor

Andon Bio measures a cell's internal supply chain in real time as proteins are being produced, linking a protein sequence's resource demands to how well it will express. The company aims to help researchers predict protein manufacturability and choose which designed sequences to build, serving protein design and bioproduction workflows.

1 investor

Andon Bio is a spinout from the University of Colorado School of Medicine developing aa-tRNA-seq, a molecular biology method for studying protein translation and tRNA aminoacylation. The company builds experimental and computational tools for research into cellular translation mechanisms.

1 investor

Andromede is a reinforcement learning data lab that programmatically generates RL environments, tasks, and verifiers from real-world data for the post-training and evaluation of AI agents. It provides a post-training and evaluation pipeline for long-horizon agent tasks.

1 investor

AndzonBio operates a suite of thematic "pipeline builder" studios that accelerate the industrial development of academic life sciences projects into biotech companies, focusing on specific therapeutic areas such as cardiovascular/renal/metabolic disorders and neurological disorders. Launched by AdBio Partners and Inserm Transfert, it provides expert support, R&D budgets, and validation to turn academic programs into viable therapeutics companies.

1 investor

AndzonBio2 develops neuroinflammation therapies targeting STING and lipid peroxidation pathways, aiming to intervene in central nervous system diseases through translational research and drug development.

1 investor

AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations. The company operates in the biotech and cancer therapeutics space, using tumor sequencing to identify neoantigens and manufacture DC and T-cell products.

1 investor

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

1 investor

Anofa uses satellite imagery and machine learning to analyze land use changes, monitor structural integrity, and track agricultural conditions, serving clients who need resilience insights for cities and infrastructure.

1 investor

Anokiwave is a fabless semiconductor company that designs highly integrated millimeter-wave silicon ICs used to build phased array active antennas. Its products serve 5G, SATCOM, and defense and aerospace markets, and the company was acquired by Qorvo in 2024.

1 investor

ANRis develops nucleic acid therapeutics using proprietary SNPD-siRNA technology for drug discovery and treatment delivery in medical and pharmaceutical applications.

1 investor

Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies. The team combines expertise in immuno-oncology, cell therapy, and translational R&D.

1 investor

Ansys provides engineering simulation software used by engineers and students to design and test products. Its tools cover simulation across areas from silicon to systems.

1 investor

This is a profile page of an individual investor/venture builder at Antares Ventures, not a company website. Antares Ventures is described as a venture capital firm investing in deep tech and sustainability-focused startups in Asia Growth Markets.

1 investor

AntennaWare designs antennas specialized for wearable devices, addressing the unique electromagnetic and form-factor constraints that general-purpose antennas fail to meet. The company serves manufacturers of wearable products across IoT, sports, and healthcare applications.

1 investor

Antenova designs and manufactures embedded antennas for IoT and cellular devices, including 4G LTE and NB-IoT applications.

1 investor

Anthriq develops the Human Body API, a hardware and software platform that reads and writes human biosignals and psychophysiological data to enable developers to build brain-computer interface and human-computer interaction products. The company provides a full-stack foundation for innovators working on neurotech and biotech applications.

1 investor

Antigma builds AI agent technology and infrastructure optimized for rapid experimentation and iteration.

1 investor

AntIML Labs creates simulation-ready 3D assets and full indoor and outdoor scenes for robotic manipulation, including detailed materials, articulated parts, collision geometry, controllable layouts, weather, and camera and range-sensor views. It also sets up repeatable tasks across simulation variants so teams can test and compare robot policies in parallel before deployment.

1 investor

Anyo Labs develops AI-enabled computational chemistry technology for drug discovery, building on research from the University of Gothenburg. The company serves pharmaceutical and biotech organizations seeking to accelerate the drug development process.

1 investor

Anyon Systems builds and delivers superconducting quantum computers designed for practical deployment in high-performance computing environments. The company serves organizations globally seeking to move quantum computing from research into operational use.

1 investor